Influence of selected lifestyle factors on breast and ovarian cancer risk in BRCA1 mutation carriers from Poland
- 27 October 2005
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 95 (2) , 105-109
- https://doi.org/10.1007/s10549-005-9051-5
Abstract
It has been estimated that the lifetime risk of breast cancer among women who inherit a BRCA1 or BRCA2 mutation is as high as 80%, and the risk estimates for ovarian cancer range from 15 to 40%. Several environmental and lifestyle factors are believed to contribute to the development of breast cancer in the general population and it is of interest to establish if these factors operate among mutation carriers as well. To evaluate the effects of age of menarche, parity, breast-feeding, oophorectomy and oral contraceptive use, as well as smoking and coffee consumption, on the risks of breast and ovarian cancer, we conducted a matched case-control study of Polish women with BRCA1 mutations. There were 348 breast cancer patients, 150 ovarian cancer patients and similar numbers of age-matched controls. BRCA1 carriers with late age of menarche, lower parity and long-term breast-feeding were less likely to develop breast cancer. Oral contraceptives protected against ovarian cancer.Keywords
This publication has 23 references indexed in Scilit:
- Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studiesJournal of Medical Genetics, 2005
- Contralateral Breast Cancer in BRCA1 and BRCA2 Mutation CarriersJournal of Clinical Oncology, 2004
- A high proportion of founder BRCA1 mutations in Polish breast cancer familiesInternational Journal of Cancer, 2004
- Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2Science, 2003
- Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 StudiesAmerican Journal of Human Genetics, 2003
- Modifiers of risk of hereditary breast and ovarian cancerNature Reviews Cancer, 2002
- Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control studyThe Lancet, 2000
- BRCA1 and BRCA2 Mutation Analysis of 208 Ashkenazi Jewish Women with Ovarian CancerAmerican Journal of Human Genetics, 2000
- Prevalence and Penetrance of BRCA1 and BRCA2 Gene Mutations in Unselected Ashkenazi Jewish Women With Breast CancerJNCI Journal of the National Cancer Institute, 1999
- Unusual case of Smith‐Lemli‐Opitz syndrome “type II”American Journal of Medical Genetics, 1995